Metabolic profiling of the anti-tumor drug regorafenib in mice
This study provided a global view of regorafenib metabolism and its potential side-effects.Graphical Abstract
Source: Journal of Pharmaceutical and Biomedical Analysis - Category: Drugs & Pharmacology Source Type: research
More News: Chemistry | Drugs & Pharmacology | Food and Drug Administration (FDA) | Liver | Study | Urology & Nephrology | USA Health